Salmonella Heidelberg dominates dairy contamination in central Ethiopia, accounting for 35.2% of typed isolates in a new Nature study, with 48.4% of serotyped isolates showing multidrug resistance.
Salmonella Heidelberg dominates dairy contamination in central Ethiopia, accounting for 35.2% of typed isolates in a new Nature study, with nearly half of all serotyped strains showing multidrug resistance.
The analysis of 71 archived isolates from raw milk, pasteurized milk, and cottage cheese in Central Oromia found that 87.3% were successfully serotyped, Nature reported. Salmonella Enteritidis (28.2%) and Salmonella Typhimurium (23.9%) followed Heidelberg in prevalence, painting a picture of diverse serovar circulation in the local dairy chain.
Raw milk and cottage cheese carried the highest contamination rates at 36.6% and 33.3% respectively, while pasteurized milk showed a lower but still concerning 25% prevalence. Resistance to ampicillin (60.6%) and tetracycline (59.2%) was widespread, and 48.4% of serotyped isolates met the definition for multidrug resistance (MDR), commonly combining resistance to ampicillin, tetracycline, and ciprofloxacin.
- The most common Salmonella type found (Heidelberg) is a known cause of severe bloodstream infections, not just stomach upset.
- Pasteurization reduces risk but did not eliminate Salmonella in this sample set, indicating potential post-processing contamination.
- Standard first-line antibiotics like ampicillin and tetracycline are failing against nearly 60% of these bacteria.
The study utilized polymerase chain reaction (PCR) confirmation followed by disk diffusion testing against 12 antimicrobial agents. Nine isolates (12.7%) remained untyped, a gap that limits full epidemiological resolution. The dominance of S. Heidelberg is notable; globally, this serovar is frequently linked to poultry but has emerged as a significant dairy-associated pathogen in East Africa.
| Antimicrobial Agent | Resistance Rate | Clinical Class |
|---|---|---|
| Ampicillin | 60.6% | Penicillin (Beta-lactam) |
| Tetracycline | 59.2% | Tetracyclines |
| Trimethoprim | 25.4% | Folate pathway inhibitor |
| Ciprofloxacin | 15.5% | Fluoroquinolone |
| Cephalosporins / Aminoglycosides / Aztreonam | High Susceptibility | Reserve / Gram-negative coverage |
MDR patterns centered on ampicillin–tetracycline–ciprofloxacin and ampicillin–tetracycline–trimethoprim–ciprofloxacin combinations. This profile complicates empirical therapy for invasive salmonellosis, where fluoroquinolones like ciprofloxacin and third-generation cephalosporins are mainstays. The 15.5% ciprofloxacin resistance rate signals erosion of a critical oral treatment option.
High susceptibility to cephalosporins, aminoglycosides, and aztreonam preserves parenteral options for severe cases, though access and cost remain barriers in resource-limited settings.
The reliance on archived isolates highlights a surveillance infrastructure gap; real-time, systematic monitoring is absent.
Funding details for the underlying laboratory work were not disclosed in the Nature publication, a standard limitation in secondary analyses of archived collections.
- Nature. Prevalence and antibiotic resistance patterns of Salmonella enterica serotypes in dairy products from Central Oromia, Ethiopia.
- World Health Organization. WHO Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics.
- Centers for Disease Control and Prevention. Salmonella: Antibiotic Resistance.
- PubMed. Salmonella Heidelberg: Epidemiology and Pathogenesis.
- PubMed. Salmonella Enteritidis and Typhimurium: Global Burden and Control Strategies.